While Internet addiction (IA) is not currently recognized in the DSM-5, new research suggests that as many as 6% of individuals worldwide could be suffering from this disorder.
A new study in the journal Diabetologia is the first to show that specific ABO blood groups may be associated with an increased risk of type 2 diabetes, although the mechanisms underlying the connection are unknown.
A new study in the journal BMJ sought to evaluate the percentage of recommendations made on "The Dr. Oz Show" and "The Doctors" that are supported by scientific evidence, topics discussed, number of recommendations made on each show, and the types and details of the recommendations.
The Food and Drug Administration (FDA) has granted accelerated approval for Opdivo (nivolumab; Bristol-Myers Squibb) for the treatment of patients with unresectable or metastatic melanoma who are unresponsive to other drugs.
Keryx announced the launch of Auryxia (ferric citrate) tablets to control serum phosphorous levels in patients with chronic kidney disease (CKD) on dialysis.
BioCryst announced that the Food and Drug Administration (FDA) has approved Rapivab (peramivir) injection for the treatment of acute uncomplicated influenza in patients ≥18 years who have been symptomatic for no more than two days.
Bisphosphonates may lower the risk of endometrial cancer, new research suggests.
Many states have been slow to adopt preparticipation physical evaluation-fourth edition (PPE-4) recommendations, with more than half of states requiring or recommending use of outdated or unidentifiable forms.
Melanoma may be dermoscopically indistinguishable from Spitz nevi, according to a new study.
Psoriasis may be associated with a higher risk of developing chronic kidney disease (CKD) and glomerulonephritis (GN).
- Over 50 FDA-Approved Meds Could Treat Ebola Infection
- Pharmacy Employees Arrested, Charged in Meningitis Outbreak
- How Effective Are Neuraminidase Inhibitors in Containing Flu?
- Ondansetron, Tramadol Drug Interaction Identified
- Pain Management in Patients with IBD: Individualizing Treatment Approaches